triple g retatrutide 10mg — Receptor Agonist (GLP-1 / GIP / Glucagon) — – Prime Labs Triple G 6 mg |

The gap between the 9 mg and 12 mg arms is narrow (about 2.3 percentage points) relative to the gap between either active arm and placebo, a pattern that has implications for dose selection in a real-world setting

The external reviewer is an independent medical professional, not an employee of the insurance company

2023;10.1002/ oby.23859

These side effects are generally mild to moderate and tend to diminish over time

US 1 review Apr 24, 2025 I've tried multiple weight loss programs, but Joey Med actually delivered results without the awkward clinic visits

Retatrutide has been tested at up to 12 mg weekly in Phase 2 and Phase 3 trials